Kenya has been selected as one of the 9 early adopter countries for the rollout of Lenacapavir (LEN), a long-acting ...

Kenya has been picked among nine countries for the trials of the new injectable HIV prevention drug that has been rolled out ...

Healthcare workers at risk as Kenya faces funding cuts threatening HIV programs. Kenya requires Sh 5.24 billion for the 2024/2025 fiscal year and Sh 13.5 billion for 2025/2026 to maintain its ...

The initiative aims to support over 14,000 young people who need to routinely test for HIV, 8,000 at-risk adolescents to help them start PrEP, and give treatment to over 1,000 young people living ...

Following Donald Trump’s funding freeze on HIV treatment and other health programmes, Kenya faces critical decisions in sustaining these initiatives.

HIV incidence rates remain higher than the level of epidemic control in many African countries. Despite the availability of cost-free, highly-effective HIV prevention interventions, such as ...

The Trump administration's cuts to the U.S. Agency for International Development have had reverberations around the world. The agency, which operated in over 100 nations and employed thousands of ...

Researchers conducted a phase 1 randomized clinical trial across clinical research centers in Uganda, Kenya, and Zambia to evaluate the safety and immunogenicity of the HIVconsvX T-cell vaccine ...